NL160814C - METHOD FOR PREPARING AN N-SUBSTITUTED PROSTAGLANDIN CARBOXAMIDE AND METHOD FOR PREPARING A MEDICINAL PRODUCT - Google Patents

METHOD FOR PREPARING AN N-SUBSTITUTED PROSTAGLANDIN CARBOXAMIDE AND METHOD FOR PREPARING A MEDICINAL PRODUCT

Info

Publication number
NL160814C
NL160814C NL7307867.A NL7307867A NL160814C NL 160814 C NL160814 C NL 160814C NL 7307867 A NL7307867 A NL 7307867A NL 160814 C NL160814 C NL 160814C
Authority
NL
Netherlands
Prior art keywords
preparing
carboxamide
medicinal product
substituted prostaglandin
prostaglandin
Prior art date
Application number
NL7307867.A
Other languages
Dutch (nl)
Other versions
NL160814B (en
NL7307867A (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NL7307867A publication Critical patent/NL7307867A/xx
Publication of NL160814B publication Critical patent/NL160814B/en
Application granted granted Critical
Publication of NL160814C publication Critical patent/NL160814C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Furan Compounds (AREA)
NL7307867.A 1972-06-07 1973-06-06 METHOD FOR PREPARING AN N-SUBSTITUTED PROSTAGLANDIN CARBOXAMIDE AND METHOD FOR PREPARING A MEDICINAL PRODUCT NL160814C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26051872A 1972-06-07 1972-06-07

Publications (3)

Publication Number Publication Date
NL7307867A NL7307867A (en) 1973-12-11
NL160814B NL160814B (en) 1979-07-16
NL160814C true NL160814C (en) 1979-12-17

Family

ID=22989486

Family Applications (2)

Application Number Title Priority Date Filing Date
NL7307867.A NL160814C (en) 1972-06-07 1973-06-06 METHOD FOR PREPARING AN N-SUBSTITUTED PROSTAGLANDIN CARBOXAMIDE AND METHOD FOR PREPARING A MEDICINAL PRODUCT
NL7812163A NL7812163A (en) 1972-06-07 1978-12-14 METHOD FOR PREPARING TRIPHENYL PHOSPHONIUM COMPOUNDS.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL7812163A NL7812163A (en) 1972-06-07 1978-12-14 METHOD FOR PREPARING TRIPHENYL PHOSPHONIUM COMPOUNDS.

Country Status (24)

Country Link
JP (2) JPS5715591B2 (en)
AR (1) AR207434A1 (en)
AT (1) AT340069B (en)
BE (1) BE800580A (en)
CA (1) CA985280A (en)
CH (3) CH593929A5 (en)
CS (1) CS200166B2 (en)
DD (2) DD115687A5 (en)
DE (1) DE2329092A1 (en)
ES (3) ES415611A1 (en)
FI (1) FI58327C (en)
FR (2) FR2187344B1 (en)
GB (2) GB1439512A (en)
HU (3) HU170200B (en)
IE (1) IE38058B1 (en)
IL (2) IL42385A (en)
IN (1) IN138966B (en)
LU (1) LU67754A1 (en)
NL (2) NL160814C (en)
NO (2) NO146538C (en)
PH (2) PH14204A (en)
SE (3) SE415883B (en)
YU (1) YU36498B (en)
ZA (1) ZA733763B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3291E (en) * 1975-04-23 1980-08-22 Upjohn Co PROCEDURE FOR PREPARING ANALOGS OF PROSTAGLANDINAS
US6395787B1 (en) 2000-02-08 2002-05-28 Allergan Sales, Inc. Ocular hypotensive lipids
US6476064B1 (en) * 2001-06-13 2002-11-05 Allergan, Inc. Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3187043A (en) * 1962-05-18 1965-06-01 Monsanto Co Monohalophosphonium halides

Also Published As

Publication number Publication date
GB1439512A (en) 1976-06-16
IL42385A (en) 1979-10-31
JPS5715591B2 (en) 1982-03-31
NO146538C (en) 1982-10-20
ES430416A1 (en) 1976-10-16
SE7608225L (en) 1976-07-19
NO146538B (en) 1982-07-12
YU36498B (en) 1984-02-29
HU170487B (en) 1977-06-28
DE2329092A1 (en) 1974-01-03
ES430417A1 (en) 1977-03-01
SE7608224L (en) 1976-07-19
DD115687A5 (en) 1975-10-12
CA985280A (en) 1976-03-09
AR207434A1 (en) 1976-10-08
JPS4954350A (en) 1974-05-27
CS200166B2 (en) 1980-08-29
NO740850L (en) 1973-12-10
DD109211A5 (en) 1974-10-20
NL160814B (en) 1979-07-16
FI58327C (en) 1981-01-12
CH591511A5 (en) 1977-09-30
HU170491B (en) 1977-06-28
FR2273814A1 (en) 1976-01-02
SE418744B (en) 1981-06-22
ATA504873A (en) 1977-03-15
AT340069B (en) 1977-11-25
YU152673A (en) 1982-02-25
ZA733763B (en) 1974-04-24
JPS5731692A (en) 1982-02-20
IL51525A0 (en) 1977-04-29
CH605887A5 (en) 1978-10-13
CH593929A5 (en) 1977-12-30
BE800580A (en) 1973-12-07
NO142784B (en) 1980-07-07
HU170200B (en) 1977-04-28
FI58327B (en) 1980-09-30
AU5643173A (en) 1974-12-05
NL7812163A (en) 1979-04-27
FR2187344A1 (en) 1974-01-18
IE38058L (en) 1973-12-07
IL42385A0 (en) 1973-07-30
NO142784C (en) 1980-10-15
SE415883B (en) 1980-11-10
NL7307867A (en) 1973-12-11
FR2187344B1 (en) 1977-10-28
GB1439511A (en) 1976-06-16
ES415611A1 (en) 1976-07-16
IN138966B (en) 1976-04-17
PH13092A (en) 1979-11-27
FR2273814B1 (en) 1977-07-08
LU67754A1 (en) 1973-12-14
PH14204A (en) 1981-04-01
IE38058B1 (en) 1977-12-21

Similar Documents

Publication Publication Date Title
NL179187C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT A FORMED MEDICINE; AND A METHOD FOR PREPARING MEDICINAL COMPOUNDS.
NL7604016A (en) PROCEDURE FOR PREPARING PROSTAGLANDIN DERIVATIVES AND PROCEDURE FOR PREPARING A MEDICINAL PRODUCT CONTAINING PROSTAGLANDIN ACTION.
NL7605381A (en) METHOD FOR PREPARING PROSTANE DERIVES AND METHOD FOR PREPARING A MEDICINAL PRODUCT WITH PROSTAGLANDIN ACTION.
NL188077C (en) FORMED PRODUCT FOR DELIVERING A MEDICINAL PRODUCT AND METHOD FOR PREPARING THEREOF.
NL7512325A (en) METHOD OF PREPARING A MEDICINAL PRODUCT.
NL173641C (en) METHOD FOR PREPARING OR MANUFACTURING A MEDICINAL PRODUCT
NL7512489A (en) METHOD FOR PREPARING ANTITUMORGLYCOSIDE MEDICINAL PRODUCTS.
NL176943C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH ANTIBIOTIC ACTION AND METHOD FOR PREPARING AN ANTIBIOTIC MEDICINE AND FORMED MEDICINE.
NL7613206A (en) METHOD OF PREPARING A MEDICINAL PRODUCT.
NL143924B (en) METHOD OF PREPARING A MEDICINAL PRODUCT AGAINST HYPERTENSION.
NL172057C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION AND AN ACTIVE INGREDIENT THEREFOR
NL172653C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH ANTIMYCOTIC ACTION AND METHOD FOR PREPARING MEDICINAL IODINE PROPARGYLOXYARENE DERIVATIVES
NL7410297A (en) METHOD OF PREPARING A MEDICINAL PRODUCT AND A SOLUTION.
NL178318C (en) METHOD FOR PREPARING ANTI-EMETICALLY ACTIVE MEDICINAL PRODUCTS AND SUITABLE ACTIVE COMPOUNDS THEREFOR
NL150436B (en) METHOD OF PREPARING A MEDICINAL PRODUCT WITH ANOREXIGENIC ACTION.
NL7506210A (en) METHOD OF PREPARING A 1H-TETRA-SOLE DERIVATIVE AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS.
NL152171B (en) METHOD OF PREPARING A MEDICINAL PRODUCT WITH VASOLICULATING PROPERTIES AND FORMED MEDICINAL PRODUCT.
NL170733C (en) METHOD FOR PREPARING OR MANUFACTURING A MEDICINAL PRODUCT AND METHOD FOR PREPARING A MEDICINAL COMPOUND
NL145216B (en) METHOD OF PREPARATION OF A CYTOSTATIC ACTIVE MEDICINAL PRODUCT.
NL141188B (en) METHOD OF PREPARING A MEDICINAL PRODUCT.
NL7411859A (en) METHOD FOR PREPARING A MEDICINAL PRODUCT.
NL160814C (en) METHOD FOR PREPARING AN N-SUBSTITUTED PROSTAGLANDIN CARBOXAMIDE AND METHOD FOR PREPARING A MEDICINAL PRODUCT
NL176142C (en) METHOD FOR PREPARING ANTI-ANTI-ANTI-INFLAMMATORY MEDICINAL PRODUCTS AND A COETECLIPATE CONTAINING SUITABLE ACETYLSALICYLIC ACID
NL7412932A (en) EQUIPMENT AND METHOD FOR PREPARING A PRESSURE GENERATING PRODUCT AT HIGH SPEED.
NL7312032A (en) METHOD FOR THE PREPARATION AND ADMINISTRATION OF A VETERINARY MEDICINAL PRODUCT.

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: PFIZER